Viewing StudyNCT00062478



Ignite Creation Date: 2024-05-05 @ 11:31 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00062478
Status: COMPLETED
Last Update Posted: 2020-03-12
First Post: 2003-06-06

Brief Title: Study of Karenitecin BNP1350 in Patients With Brain Tumors
Sponsor: BioNumerik Pharmaceuticals Inc
Organization: BioNumerik Pharmaceuticals Inc

Organization Data

Organization: BioNumerik Pharmaceuticals Inc
Class: INDUSTRY
Study ID: KTN20405
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: BioNumerik Pharmaceuticals Inc
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Crown Bioscience INDUSTRY